论文部分内容阅读
目的探讨静脉注射蔗糖铁(森铁能)治疗血液透析(HD)患者肾性贫血的有效性和安全性。方法选择60例患者分为蔗糖铁组和乳酸亚铁口服液组,每组30例。蔗糖铁组:每周第1次透析时从透析管路静脉端将蔗糖铁100mg+10mL生理盐水推注;口服铁组:乳酸亚铁口服液100mg,每日3次,两组病例观察10周;均同时使用基因重组人
Objective To investigate the efficacy and safety of intravenous injection of sucrose iron in the treatment of renal anemia in hemodialysis (HD) patients. Methods Sixty patients were divided into iron sucrose group and ferrous lactate oral liquid group, 30 cases in each group. Sucrose iron group: the first dialysis per week from the dialysis line venous end will sucrose iron 100mg +10 mL saline bolus; oral iron group: ferrous lactate oral solution 100mg, 3 times a day, two groups of patients observed for 10 weeks ; Both using gene recombinant human